OBJECTIVE: Betaine is a substrate in the betaine-homocysteine methyltransferase reaction, converting homocysteine to methionine. There are only sparse data on plasma betaine as a determinant of the plasma total homocysteine (tHcy) concentration. METHODS AND RESULTS:Ninety patients undergoingcoronary angiography were randomized into 4 groups administered oral: (1) folic acid (0.8 mg), vitamin B12 (0.4 mg), and vitamin B6 (40 mg); (2) folic acid and vitamin B12; (3) vitamin B6 alone; or (4) placebo. Nonfasting blood samples were collected at baseline and 3, 14, and 28 days and 3, 6, and 12 months after treatment start. A 4-hour methionine-loading test (0.1 g/kg) was performed at baseline and after 3 months. At baseline, median (interquartile range) plasma betaine was 36.9 micromol/L (range: 30.3 to 46.8) and was increased by 15% after methionine loading. The postmethionine load (PML) increase in tHcy was inversely related to plasma betaine (beta=-0.29, P=0.02) and even more strongly to PML betaine (beta=-0.47, P<0.001). After 3 months of intervention, the relation between the PML increase in tHcy and PML betaine was weakened (beta=-0.33, P=0.007). CONCLUSIONS:Plasma betaine is a strong determinant of the PML increase in tHcy in subjects not supplemented with B-vitamins.
RCT Entities:
OBJECTIVE:Betaine is a substrate in the betaine-homocysteine methyltransferase reaction, converting homocysteine to methionine. There are only sparse data on plasma betaine as a determinant of the plasma total homocysteine (tHcy) concentration. METHODS AND RESULTS: Ninety patients undergoing coronary angiography were randomized into 4 groups administered oral: (1) folic acid (0.8 mg), vitamin B12 (0.4 mg), and vitamin B6 (40 mg); (2) folic acid and vitamin B12; (3) vitamin B6 alone; or (4) placebo. Nonfasting blood samples were collected at baseline and 3, 14, and 28 days and 3, 6, and 12 months after treatment start. A 4-hour methionine-loading test (0.1 g/kg) was performed at baseline and after 3 months. At baseline, median (interquartile range) plasma betaine was 36.9 micromol/L (range: 30.3 to 46.8) and was increased by 15% after methionine loading. The postmethionine load (PML) increase in tHcy was inversely related to plasma betaine (beta=-0.29, P=0.02) and even more strongly to PML betaine (beta=-0.47, P<0.001). After 3 months of intervention, the relation between the PML increase in tHcy and PML betaine was weakened (beta=-0.33, P=0.007). CONCLUSIONS: Plasma betaine is a strong determinant of the PML increase in tHcy in subjects not supplemented with B-vitamins.
Authors: Susan M Wernimont; Andrew G Clark; Patrick J Stover; Martin T Wells; Augusto A Litonjua; Scott T Weiss; J Michael Gaziano; Pantel S Vokonas; Katherine L Tucker; Patricia A Cassano Journal: J Nutr Date: 2012-05-30 Impact factor: 4.798
Authors: Belal Alshaikh; Joan I Schall; Asim Maqbool; Maria Mascarenhas; Michael J Bennett; Virginia A Stallings Journal: Nutr Res Date: 2015-12-29 Impact factor: 3.315
Authors: Jung Eun Lee; Paul F Jacques; Lauren Dougherty; Jacob Selhub; Edward Giovannucci; Steven H Zeisel; Eunyoung Cho Journal: Am J Clin Nutr Date: 2010-03-10 Impact factor: 7.045
Authors: Stephanie E Chiuve; Edward L Giovannucci; Susan E Hankinson; Steven H Zeisel; Lauren W Dougherty; Walter C Willett; Eric B Rimm Journal: Am J Clin Nutr Date: 2007-10 Impact factor: 7.045